This field guide is a companion document to WHO's "Guidelines for the programmatic management of drug-resistant tuberculosis."
Favorite
2010
The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.
This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.
Favorite
International Agencies
Policy Makers
2010
This interactive resource aims to offer practical tools to nurses and anyone else involved in caring for patients, families and communities affected by TB including drug-resistant TB.
Favorite
2010
Popularly known as “The Orange Guide”, the 6th edition of this small book provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens.
Favorite
International Agencies
Managers and Supervisors
2010
This new report on anti-tuberculosis (TB) drug resistance by the World Health Organization (WHO) updates “Anti-tuberculosis drug resistance in the world: Report No. 4” published by WHO in 2008. It summarizes the latest data and provides latest estimates of the global epidemic of multidrug and extensively drug-resistant tuberculosis (M/XDR-TB)...
Favorite
International Agencies
Policy Makers
2010
This report was produced by a Federal TB task force that was reconvened by CDC in November 2006. The task force drafted an updated action plan to address the issue of multidrug-resistant TB (MDR TB) and extensively drug-resistant TB (XDR TB). Task force members were charged with articulating the most pressing problems, identifying barriers to improvement, and recommending specific action steps to improve prevention and control of XDR TB in their respective areas...
Favorite
2009
WHO's report on Global TB Control compiles data from over 200 countries and territories each year, monitoring the scale and direction of TB epidemics, implementation and impact of the Stop TB Strategy, and progress towards the Millennium Development Goals.
Order online: http://apps.who.int/bookorders/anglais/detart1...
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2009
This Special Report from Medecins Sans Frontieres/Doctors Without Borders highlights the challenges, such as TB/HIV coinfection and drug resistance, faced in the fight against TB. The report also provides real-life examples of people living with TB.
Favorite
International Agencies
Policy Makers
2009
This report presents results from an expert panel convened by CDC to examine the current status of rapid drug-resistance (DR) testing in the United States; to research published evidence and current guidelines; and to provide guidance and make recommendations to CDC for developing a system to provide access to rapid drug-susceptibility testing to all TB control programs in the United States...
Favorite
2009
This report describes the investigation by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), which initially identified five confirmed cases of multidrug-resistant tuberculosis (MDR TB) in two distinct clusters, characterized by two distinct geographic locations, genotypes, and drug-susceptibility patterns in the Federated States of Micronesia...
Favorite
2009
This edition of the Los Angeles County Public Health Newsletter, The Public's Health, discusses World TB Day, drug-resistant TB, management of non-compliant TB patients, and the burden of TB in Los Angeles county.
Favorite
Health Educators/Communicators
2009
This tool will assist countries and partners in conducting assessments of national tuberculosis (TB) programs to identify strengths and gaps related to preventing, diagnosing, and treating multidrug-resistant TB. It provides the starting point for planning for new activities to address drug-resistant TB...
Favorite
International Agencies
Managers and Supervisors
2009
This booklet calls upon national programs for TB control, donors, financing institutions, civil society, media, and communities to join hands in intensifying the fight against drug-resistant TB.
Favorite
International Agencies
Policy Makers
2009
This guideline is intended to help nurses in their role of detecting TB cases, providing care, and managing TB treatment. It provides a nursing approach to planning and delivering patient care, aimed at improving access and quality of care throughout the treatment period. It offers a review of TB and multidrug-resistant TB (MDR TB) and the directly observed treatment short-course (DOTS) and DOTS-Plus strategy, as well as guidance on how to adapt TB control information for local program implementation...
Favorite
2008
This manual describes policies, protocols and recommendations for the prevention, treatment and control of tuberculosis from the New York City Department of Health and Mental Hygiene (NYC DOHMH). The protocols address testing, preventive treatment, initial evaluation for TB, treatment of TB disease and drug-resistant TB, monitoring and follow-up evaluation, infection control, and case management...
Favorite
2008
